Dimitris Kadis
Directeur Général chez Pharmathen SA
Profil
Dimitris Kadis is currently the Group Chief Executive Officer at Pharmathen SA. He is also the Chief Executive Officer at Pharmathen Global BV.
In addition, he holds the position of Director & Vice President-Corporate Development at Pharmathen Pharmaceuticals SA and Pharmathen International SA. Mr. Kadis has an MBA from Warwick Business School and an undergraduate degree from the National & Kapodistrian University of Athens.
Postes actifs de Dimitris Kadis
| Sociétés | Poste | Début |
|---|---|---|
Pharmathen International SA
 Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Directeur/Membre du Conseil | 01/01/2003 |
Pharmathen Pharmaceuticals SA
 Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Directeur/Membre du Conseil | - |
Pharmathen SA
 Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Directeur Général | 01/07/2019 |
Pharmathen Global BV
 Pharmathen Global BV Miscellaneous Commercial ServicesCommercial Services Pharmathen Global BV is a Dutch research-centered pharmaceutical company that specializes in developing innovative generic products. The company is based in Amstelveen, Netherlands, and has subsidiaries in Greece. The company offers a complete package of integrated services, including finished products, know-how, and technological and regulatory support to partners worldwide. Pharmathen was founded in 1969, and Dimitris Kadis has been the CEO of the company since 2003. | Directeur Général | 01/01/2003 |
Formation de Dimitris Kadis
| Warwick Business School | Masters Business Admin |
| National & Kapodistrian University of Athens | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pharmathen Pharmaceuticals SA
Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Health Technology |
Pharmathen Global BV
Pharmathen Global BV Miscellaneous Commercial ServicesCommercial Services Pharmathen Global BV is a Dutch research-centered pharmaceutical company that specializes in developing innovative generic products. The company is based in Amstelveen, Netherlands, and has subsidiaries in Greece. The company offers a complete package of integrated services, including finished products, know-how, and technological and regulatory support to partners worldwide. Pharmathen was founded in 1969, and Dimitris Kadis has been the CEO of the company since 2003. | Commercial Services |
